Anondita Medicare IPO

About Anondita Medicare IPO

The IPO of Anondita Medicare Ltd comprises a fresh issue of up to 47,93,000 equity shares of face value of ₹10 each. There is no offer for sale in this 100% book-built issue. The price band is ₹137 to ₹145 per share and the lot size is 1000 shares.

The IPO opens on August 22, 2025 and closes on August 26, 2025. The listing date is on or before September 1, 2025 and the allotment date is on or before August 28, 2025. The credit of shares to the Demat account will take place on August 29, 2025, while the initiation of refund will take place on August 29, 2025.

Anondita Medicare Ltd is a manufacturer of male condoms with a variety of flavours, with its flagship product marketed and sold under the brand “COBRA”. It has an installed production capacity of nearly 562 million condoms per annum.

Objectives of Anondita Medicare IPO

The company plans to utilise the proceeds for:

• Funding capital expenditure requirements for the purchase of equipment/machineries
• Funding the working capital requirements of the company
• Meet out the expenses for unidentified acquisition and general corporate purposes

Industry Outlook

The Indian condom market has demonstrated exceptional growth through 2024, reaching a valuation of approximately USD 245 million, representing year-on-year growth of 8.4%. Market projections indicate continued robust expansion, with expectations of reaching USD 410 million by 2030, reflecting a compound annual growth rate (CAGR) of 8.9% over the forecast period.

This growth trajectory significantly outpaces global market averages, driven by India's unique demographic advantages, evolving social attitudes, and supportive government policies. The market's expansion reflects successful awareness campaigns, improved distribution networks, and increasing acceptance of contraceptive products across diverse population segments.

The Indian condom market represents approximately 2.8% of the global condom market by value but accounts for nearly 15% by volume, reflecting the price-sensitive nature of the domestic market and the emphasis on accessible contraception for public health objectives.

Company Information

Anondita Medicare Ltd is a manufacturer of male condoms with a variety of flavours, with its flagship product marketed and sold under the brand “COBRA”. It has an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated June 04, 2025. Further, to follow sustainable production practices, the company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant.

Strengths of Anondita Medicare IPO

The strengths of Anondita Medicare Ltd and the basis of its issue price are:

• Production capabilities
• Experienced management team and a motivated and efficient workforce
• Cordial relations with its consumers
• Quality assurance and control

Risks of Anondita Medicare IPO

• Dependence on top 10 customers for significant portion of revenues
• Dependence on government tenders exposes us to risks of disqualification and revenue loss
• Fluctuations in interest rates or changes in repayment terms may adversely impact its financial position
• Majority of assets, including both movable and immovable, have not yet been transferred under the name of the company
• Losses incurred by its subsidiary may require future funding and impact its financial condition
• The company has incurred negative cash flows in the past. Sustained negative cash flow could impact their business.

IPO Registrar and Book Running Lead Manager

• IPO Registrar: Maashitla Securities Pvt Ltd
• Book Running Lead Manager: Narnolia Financial Services Ltd

Business Model

Manufacturer of male condoms under the brand ‘Cobra’, Anondita Medicare Ltd’s condoms are available under different flavours such as strawberry, mint, chocolate, butterscotch, coffee, bubble gum, etc. Encouraged by demand and overwhelming responses from consumers it has also started the production of female condoms.

Company Growth Trajectory

The company’s revenue PAT increased from ₹ (0.0038) crores in FY 24 to ₹10.7998 crores in FY 25. Its EBITDA increased from ₹ (0.0038) crores in FY 24 to ₹17.8846 crores in FY 25. Quality assurance and control coupled with cordial relations with customers has helped the company grow with time.

Market Position

Incorporated in March 2024, Anondita Medicare Ltd boasts a state-of-the-art plant located in Noida, Uttar Pradesh. Its manufacturing capability is supported by 11 existing manufacturing lines at the moment.

How to Check the Allotment Status of Anondita Medicare IPO?

Via the Registrar’s Website

• Visit the official website of Maashitla Securities Pvt Ltd
• Click on ‘Public Issues’ under ‘Allotment Status’
• Choose the Company Name from dropdown and enter either your PAN, Application No or Demat Account No
• Click on ‘Submit’ to know the status

Check on the National Stock Exchange Website

The National Stock Exchange (NSE) has an IPO Bid Verification module. You can use it to check the status of Anondita Medicare Ltd. Go to www.nseindia.com and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'.

On the NSE IPO Bid Verification page, enter:

• Company name from dropdown
• Application number
• PAN Then click 'Submit' to know the allotment status.

How to Apply for Anondita Medicare IPO?

• Step 1: Log in to your Kotak Neo Demat account: Log in to your Demat account to access IPO investments. Next, select the current IPO section.
• Step 2: Specify IPO details: Enter the number of lots and the price you wish to apply for.
• Step 3: Enter UPI ID After entering your UPI ID, click submit. This will place your bid with the exchange.
• Step 4: Mandate Notification: Your UPI app will receive a mandate notification to block funds.
• Step 5: Approve Request Your funds will be blocked once you approve the mandate request on your UPI.